202 related articles for article (PubMed ID: 38407017)
1. Spectral Fluorescence Pathology of Protein Misfolding Disorders.
Stepanchuk AA; Stys PK
ACS Chem Neurosci; 2024 Mar; 15(5):898-908. PubMed ID: 38407017
[TBL] [Abstract][Full Text] [Related]
2. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission.
Moreno-Gonzalez I; Soto C
Semin Cell Dev Biol; 2011 Jul; 22(5):482-7. PubMed ID: 21571086
[TBL] [Abstract][Full Text] [Related]
3. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
Yoshida K; Higuchi K; Ikeda S
Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein misfolding and aggregation by natural phenolic compounds.
Dhouafli Z; Cuanalo-Contreras K; Hayouni EA; Mays CE; Soto C; Moreno-Gonzalez I
Cell Mol Life Sci; 2018 Oct; 75(19):3521-3538. PubMed ID: 30030591
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive review of protein misfolding disorders, underlying mechanism, clinical diagnosis, and therapeutic strategies.
Basha S; Mukunda DC; Rodrigues J; Gail D'Souza M; Gangadharan G; Pai AR; Mahato KK
Ageing Res Rev; 2023 Sep; 90():102017. PubMed ID: 37468112
[TBL] [Abstract][Full Text] [Related]
6. Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease.
Singh N; Haldar S; Tripathi AK; McElwee MK; Horback K; Beserra A
Antioxid Redox Signal; 2014 Jul; 21(3):471-84. PubMed ID: 24512387
[TBL] [Abstract][Full Text] [Related]
7. Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases.
Sarnataro D
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304819
[TBL] [Abstract][Full Text] [Related]
8. Animal models for prion-like diseases.
Fernández-Borges N; Eraña H; Venegas V; Elezgarai SR; Harrathi C; Castilla J
Virus Res; 2015 Sep; 207():5-24. PubMed ID: 25907990
[TBL] [Abstract][Full Text] [Related]
9. The role of activity in synaptic degeneration in a protein misfolding disease, prion disease.
Caleo M; Restani L; Vannini E; Siskova Z; Al-Malki H; Morgan R; O'Connor V; Perry VH
PLoS One; 2012; 7(7):e41182. PubMed ID: 22815961
[TBL] [Abstract][Full Text] [Related]
10. Targeting Neuroinflammation by Pharmacologic Downregulation of Inflammatory Pathways Is Neuroprotective in Protein Misfolding Disorders.
Risen SJ; Boland SW; Sharma S; Weisman GM; Shirley PM; Latham AS; Hay AJD; Gilberto VS; Hines AD; Brindley S; Brown JM; McGrath S; Chatterjee A; Nagpal P; Moreno JA
ACS Chem Neurosci; 2024 Apr; 15(7):1533-1547. PubMed ID: 38507813
[TBL] [Abstract][Full Text] [Related]
11. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
12. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
Victoria GS; Zurzolo C
J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
[TBL] [Abstract][Full Text] [Related]
13. [Neurodegenerative amyloidoses: the yeast model].
Vishnevskaia AB; Kushnirov VV; Ter-Avanesian MD
Mol Biol (Mosk); 2007; 41(2):346-54. PubMed ID: 17514901
[TBL] [Abstract][Full Text] [Related]
14. "Prion-like" templated misfolding in tauopathies.
Clavaguera F; Lavenir I; Falcon B; Frank S; Goedert M; Tolnay M
Brain Pathol; 2013 May; 23(3):342-9. PubMed ID: 23587140
[TBL] [Abstract][Full Text] [Related]
15. Protein misfolding and neurodegeneration.
Soto C; Estrada LD
Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
[TBL] [Abstract][Full Text] [Related]
16. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Ritchie DL; Barria MA
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
[TBL] [Abstract][Full Text] [Related]
17. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
Costanzo M; Zurzolo C
Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
[TBL] [Abstract][Full Text] [Related]
18. Unravelling protein aggregation as an ageing related process or a neuropathological response.
Trigo D; Nadais A; da Cruz E Silva OAB
Ageing Res Rev; 2019 May; 51():67-77. PubMed ID: 30763619
[TBL] [Abstract][Full Text] [Related]
19. Shape matters: the complex relationship between aggregation and toxicity in protein-misfolding diseases.
Ries HM; Nussbaum-Krammer C
Essays Biochem; 2016 Oct; 60(2):181-190. PubMed ID: 27744334
[TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetes as a protein misfolding disease.
Mukherjee A; Morales-Scheihing D; Butler PC; Soto C
Trends Mol Med; 2015 Jul; 21(7):439-49. PubMed ID: 25998900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
